120 related articles for article (PubMed ID: 19641220)
1. High-throughput, cell-free, liposome-based approach for assessing in vitro activity of lipid kinases.
Demian DJ; Clugston SL; Foster MM; Rameh L; Sarkes D; Townson SA; Yang L; Zhang M; Charlton ME
J Biomol Screen; 2009 Aug; 14(7):838-44. PubMed ID: 19641220
[TBL] [Abstract][Full Text] [Related]
2. A high-throughput liposome substrate assay with automated lipid extraction process for PI 3-kinase.
Lingaraj T; Donovan J; Li Z; Li P; Doucette A; Harrison S; Ecsedy JA; Dang L; Zhang W
J Biomol Screen; 2008 Oct; 13(9):906-11. PubMed ID: 18812570
[TBL] [Abstract][Full Text] [Related]
3. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
[TBL] [Abstract][Full Text] [Related]
4. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform.
Lebakken CS; Riddle SM; Singh U; Frazee WJ; Eliason HC; Gao Y; Reichling LJ; Marks BD; Vogel KW
J Biomol Screen; 2009 Sep; 14(8):924-35. PubMed ID: 19564447
[TBL] [Abstract][Full Text] [Related]
5. High-throughput biochemical kinase selectivity assays: panel development and screening applications.
Card A; Caldwell C; Min H; Lokchander B; Hualin Xi ; Sciabola S; Kamath AV; Clugston SL; Tschantz WR; Leyu Wang ; Moshinsky DJ
J Biomol Screen; 2009 Jan; 14(1):31-42. PubMed ID: 19073965
[TBL] [Abstract][Full Text] [Related]
6. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
7. Multiplexing terbium- and europium-based TR-FRET readouts to increase kinase assay capacity.
Horton RA; Vogel KW
J Biomol Screen; 2010 Sep; 15(8):1008-15. PubMed ID: 20460248
[TBL] [Abstract][Full Text] [Related]
8. Small-molecule kinase-inhibitor target assessment.
Kung C; Shokat KM
Chembiochem; 2005 Mar; 6(3):523-6. PubMed ID: 15696508
[TBL] [Abstract][Full Text] [Related]
9. Development of high-throughput TR-FRET and AlphaScreen assays for identification of potent inhibitors of PDK1.
Xu Z; Nagashima K; Sun D; Rush T; Northrup A; Andersen JN; Kariv I; Bobkova EV
J Biomol Screen; 2009 Dec; 14(10):1257-62. PubMed ID: 19822882
[TBL] [Abstract][Full Text] [Related]
10. The Substrate-Activity-Screening methodology applied to receptor tyrosine kinases: a proof-of-concept study.
Chapelat J; Berst F; Marzinzik AL; Moebitz H; Drueckes P; Trappe J; Fabbro D; Seebach D
Eur J Med Chem; 2012 Nov; 57():1-9. PubMed ID: 23041456
[TBL] [Abstract][Full Text] [Related]
11. Three mechanistically distinct kinase assays compared: Measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors.
Kashem MA; Nelson RM; Yingling JD; Pullen SS; Prokopowicz AS; Jones JW; Wolak JP; Rogers GR; Morelock MM; Snow RJ; Homon CA; Jakes S
J Biomol Screen; 2007 Feb; 12(1):70-83. PubMed ID: 17166826
[TBL] [Abstract][Full Text] [Related]
12. Integration of virtual screening with high-throughput screening for the identification of novel Rho-kinase I inhibitors.
Gong LL; Fang LH; Peng JH; Liu AL; Du GH
J Biotechnol; 2010 Feb; 145(3):295-303. PubMed ID: 19963024
[TBL] [Abstract][Full Text] [Related]
13. Novel in vitro protein fragment complementation assay applicable to high-throughput screening in a 1536-well format.
Hashimoto J; Watanabe T; Seki T; Karasawa S; Izumikawa M; Seki T; Iemura S; Natsume T; Nomura N; Goshima N; Miyawaki A; Takagi M; Shin-Ya K
J Biomol Screen; 2009 Sep; 14(8):970-9. PubMed ID: 19641222
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of various in vitro COT kinase assay formats and their applications in inhibitor identification and characterization.
Jia Y; Quinn CM; Clabbers A; Talanian R; Xu Y; Wishart N; Allen H
Anal Biochem; 2006 Mar; 350(2):268-76. PubMed ID: 16356459
[TBL] [Abstract][Full Text] [Related]
15. A homogeneous time-resolved fluorescence-based high-throughput screening system for discovery of inhibitors of IKKbeta-NEMO interaction.
Gotoh Y; Nagata H; Kase H; Shimonishi M; Ido M
Anal Biochem; 2010 Oct; 405(1):19-27. PubMed ID: 20522330
[TBL] [Abstract][Full Text] [Related]
16. Selectivity of kinase inhibitor fragments.
Bamborough P; Brown MJ; Christopher JA; Chung CW; Mellor GW
J Med Chem; 2011 Jul; 54(14):5131-43. PubMed ID: 21699136
[TBL] [Abstract][Full Text] [Related]
17. A kinase-focused compound collection: compilation and screening strategy.
Sun D; Chuaqui C; Deng Z; Bowes S; Chin D; Singh J; Cullen P; Hankins G; Lee WC; Donnelly J; Friedman J; Josiah S
Chem Biol Drug Des; 2006 Jun; 67(6):385-94. PubMed ID: 16882313
[TBL] [Abstract][Full Text] [Related]
18. Development and application of PI3K assays for novel drug discovery.
Yanamandra M; Mitra S; Giri A
Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
[TBL] [Abstract][Full Text] [Related]
19. Trends in kinase selectivity: insights for target class-focused library screening.
Posy SL; Hermsmeier MA; Vaccaro W; Ott KH; Todderud G; Lippy JS; Trainor GL; Loughney DA; Johnson SR
J Med Chem; 2011 Jan; 54(1):54-66. PubMed ID: 21128601
[TBL] [Abstract][Full Text] [Related]
20. Kinetic-based high-throughput screening assay to discover novel classes of macrophage migration inhibitory factor inhibitors.
Ouertatani-Sakouhi H; Liu M; El-Turk F; Cuny GD; Glicksman MA; Lashuel HA
J Biomol Screen; 2010 Apr; 15(4):347-58. PubMed ID: 20231420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
